NMX-3

N/A

Report date: 2022/07/05 15:20:11
NME

Base Information

Drug NameNMX-3
Drug Alias NameNMX-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 11 receptor alpha antagonistsAMP-activated protein kinases activatorsSignal transducer and activator of transcription 3 inhibitors
TargetsInterleukin 11 receptor alphaAMP-activated protein kinasesSignal transducer and activator of transcription 3
Therapy Area/IndicationsHematologic NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovomedix LLC
China Registration ClassN/A

Develop Information

Active CompaniesNovomedix LLC
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A